Detecting SARS-CoV-2 with CRISPR

Presented at: CRISPR 2021
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

The COVID-19 pandemic demonstrated the need for rapid, accurate diagnostic tests that could be developed and deployed quickly. Since the company’s founding in 2018, Mammoth has been advancing our CRISPR-based DETECTRTM technology to enable diagnostic solutions across the continuum of molecular testing. By programming a Cas protein with a sequence specific gRNA, DETECTRTM couples a highly specific target recognition event with cleavage of a reporter molecule, generating a measurable signal. In response to the pandemic, Mammoth rapidly reconfigured our DETECTRTM platform to detect SARS-CoV-2, demonstrating the speed and accuracy of CRISPR-based diagnostics for COVID-19. Mammoth has further implemented its CRISPR technology into device formats that enable high-throughput and decentralized testing solutions. The platform nature of the DETECTRTM platform will continue to democratize diagnostics for SARS-CoV-2 and beyond. 

Learning Objectives:

1. Define how CRISPR proteins enable disease diagnostics.

2. Explain the application of CRISPR diagnostics to the COVID-19 pandemic.


Show Resources
You May Also Like
MAY 04, 2022 10:30 AM PDT
C.E. CREDITS
MAY 04, 2022 10:30 AM PDT
The coronavirus SARS-CoV-2 has led to a worldwide pandemic. Beside respiratory symptoms, infected people may develop neurologic dysfunctions such as loss of smell and taste, also seizures, a...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
Neurological manifestations, including headache, altered mental status, and stroke, are a major complication of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and cor...
C.E. CREDITS
Diagnostics have never been more important or visible on the world stage as they are today in the midst of the COVID-19 global pandemic. Mara will speak about how COVID diagnostics have been...
Loading Comments...
Show Resources